Source BioScience News
In addition to the news article below, please refer to the regulatory news announcements
available from the investor relations page.
Source BioScience to offer Fluidigm SNP genotyping service
26 November 2009
Source BioScience provides Interim Management Statement
17 November 2009
The Company today provides its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules, relating to the period from 1 July 2009 to 17 November 2009.
Interim Results
25 August 2009
The Company today announced its interim results for the six months ended 30 June 2009.
Source BioScience extends agreement with Cervical Screening Wales
23 July 2009
The Company is pleased to announce an extension to the existing agreement to supply cytology services and automated imaging technology to Cervical Screening Wales.
Result of Annual General Meeting
4 June 2009
Source BioScience confirms that all resolutions put to the Annual General Meeting held on 4th June 2009 were duly passed by Shareholders.Details of proxy voting on the resolutions put to Shareholders at the Annual General Meeting are available on the Company's website - www.sourcebioscience.com.At the AGM the Chairman, Laurie Turnbull, delivered his annual statement, details of which are contained under 'More information'.
Attendance at ICR Centennial and ERBI Annual Conferences
27 May 2009
Dr Jackie Rodgers, Head of Business Development, Pharma Biotech Worldwide for Source BioScience, the Nottingham, UK based healthcare and biotechnology company, will be attending a couple of key conferences in the coming weeks, to discuss partnering opportunities with pharmaceutical and biotech companies. The first of these will be the
ICR Centennial Conference at the Queen Elizabeth Centre in London, 8th-9th June, followed by the
ERBI Annual Conference in Cambridge, 10th-12th June. The expertise offered by Source BioScience supports clinical trials with contract research services, assisting biomarker discovery and validation, pharmacogenomics and companion diagnostics. Dr Rodgers will also be evaluating opportunities for in-licensing and developing reference laboratory services for novel diagnostic, prognostic and predictive tests.Dr Rodgers would be pleased to meet with companies wishing to discuss how Source BioScience could be of assistance in the areas of expertise outlined. Please contact her via email - jackie.rodgers@sourcebioscience.com.
American Society of Clinical Oncology (ASCO) Annual Meeting – Orlando, Florida 29 May – 2 June 2009
21 May 2009
Dr Cliff Murray, Head of Research and Development for Source BioScience, the Nottingham, UK based healthcare and biotechnology company, will be attending the
ASCO Annual Meeting to discuss partnering opportunities with pharmaceutical and biotech companies. The expertise offered by Source BioScience supports clinical trials with contract research services, assisting biomarker discovery and validation, pharmacogenomics and biobanking. Dr Murray will also be evaluating opportunities for in-licensing and developing reference laboratory services for novel diagnostic, prognostic and predictive tests.Dr Murray would be pleased to meet with companies wishing to discuss how Source BioScience could be of assistance in the areas of expertise outlined. Please contact Dr Murray via email - cliff.murray@sourcebioscience.com.
Source BioScience provides Interim Management Statement
18 May 2009
The Company today provides its Interim Management Statement as required by the UK Listing Authority's Disclosure and Transparency Rules, relating to the period from 1 January 2009 to 18 May 2009.
Preliminary results for the year ended 31 December 2008
17 March 2009
The Board of Source BioScience plc today announces its unaudited results for the year ended 31 December 2008.